Anti-KIR autoantibodies were identified in sera from 23.0% of patients with SLE, 10.9% of patients with pSS, 12.5% of patients with SSc, and 3.0% of HD. This evidence concerns the gene KIR3DL1 and systemic lupus erythematosus.